Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial

INTRODUCTION: Although prophylactic tranexamic acid (TXA) is a safe, low-cost option to reduce bleeding in patients undergoing total hip replacement (THR), its optimal dose and duration is unknown. We compared the safety and effectiveness of TXA given as either a single injection or continuous infus...

Descripción completa

Detalles Bibliográficos
Autores principales: Hourlier, Hervé, Fennema, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159839/
https://www.ncbi.nlm.nih.gov/pubmed/24062227
http://dx.doi.org/10.5301/hipint.5000090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159839/
https://www.ncbi.nlm.nih.gov/pubmed/24062227
http://dx.doi.org/10.5301/hipint.5000090

Ejemplares similares